| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11724475AEP2566450A2 (en) | 2010-05-04 | 2011-05-02 | Pharmaceutical compositions comprising cefetamet |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/03545 | 2010-05-04 | ||
| TR201003545 | 2010-05-04 |
| Publication Number | Publication Date |
|---|---|
| WO2011139255A2 WO2011139255A2 (en) | 2011-11-10 |
| WO2011139255A3true WO2011139255A3 (en) | 2012-05-03 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/TR2011/000133WO2011139255A2 (en) | 2010-05-04 | 2011-05-02 | Pharmaceutical compositions comprising cefetamet |
| Country | Link |
|---|---|
| EP (1) | EP2566450A2 (en) |
| WO (1) | WO2011139255A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013109202A2 (en)* | 2012-01-18 | 2013-07-25 | Mahmut Bilgic | Pharmaceutical compounds comprising cefetamet |
| CN104876947B (en)* | 2015-05-06 | 2017-09-29 | 山东罗欣药业集团股份有限公司 | Cefetamet Pivoxil Hydrochloride hydrate crystal and its dispersible tablet |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1600313A (en)* | 2003-09-28 | 2005-03-30 | 东北制药总厂 | Cefetamet pivoxil hydrochloride dispersion dispersion tablets and preparation method |
| CN101612138A (en)* | 2009-07-16 | 2009-12-30 | 浙江亚太药业股份有限公司 | Cefetamet pivoxil hydrochloride capsule and preparation method thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4396681A (en) | 1981-06-10 | 1983-08-02 | Essex Chemical Corporation | Process for coating one pot moisture curable coating composition onto non-porous substrate and article |
| CN1650868A (en) | 2004-12-02 | 2005-08-10 | 四川川投医药生物技术有限责任公司 | Compound medicinal preparation for treating pneumonia infection disease and its preparation method |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1600313A (en)* | 2003-09-28 | 2005-03-30 | 东北制药总厂 | Cefetamet pivoxil hydrochloride dispersion dispersion tablets and preparation method |
| CN101612138A (en)* | 2009-07-16 | 2009-12-30 | 浙江亚太药业股份有限公司 | Cefetamet pivoxil hydrochloride capsule and preparation method thereof |
| Publication number | Publication date |
|---|---|
| WO2011139255A2 (en) | 2011-11-10 |
| EP2566450A2 (en) | 2013-03-13 |
| Publication | Publication Date | Title |
|---|---|---|
| WO2012021715A3 (en) | Stable formulations of linaclotide | |
| WO2010092090A3 (en) | Novel salts of sitagliptin | |
| EP2535339A4 (en) | Polymorphs of dasatinib, preparation methods and pharmaceutical compositions thereof | |
| WO2011098582A3 (en) | Novel crystalline forms of ivabradine hydrochloride | |
| WO2012174487A3 (en) | Bromodomain inhibitors and uses thereof | |
| WO2012151512A3 (en) | Bromodomain inhibitors and uses thereof | |
| WO2012075383A3 (en) | Bromodomain inhibitors and uses thereof | |
| WO2011130615A3 (en) | Preparation of lacosamide | |
| WO2012174158A3 (en) | Administration of benzodiazepine | |
| WO2011017502A3 (en) | Linaclotide-containing formulations for oral administration | |
| WO2011157721A3 (en) | Ivabradine-containing pharmaceutical composition | |
| ZA201209739B (en) | Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof | |
| WO2013134534A3 (en) | Solid state forms of cabazitaxel and processes for preparation thereof | |
| WO2013055684A8 (en) | Rasagiline citramide | |
| PL2562172T3 (en) | Sphaelactone derivatives, their pharmaceutical compositions, preparation methods and uses | |
| WO2012070062A3 (en) | Novel polymorph of nilotinib hydrochloride | |
| WO2012101653A3 (en) | Modified release pharmaceutical compositions memantine | |
| WO2010049449A3 (en) | Novel salts of sunitinib | |
| WO2014068586A3 (en) | Solid oral compositions of tolvaptan | |
| WO2014203275A3 (en) | An improved process for the preparation of apixaban and intermediates thereof | |
| WO2013057741A3 (en) | Pharmaceutical compositions of ursodeoxycholic acid | |
| WO2014033526A9 (en) | Pharmaceutical compositions of etoricoxib | |
| WO2012137227A3 (en) | Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof | |
| WO2013128379A3 (en) | Crystalline polymorphic forms of linagliptin | |
| WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium |
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | Ref document number:11724475 Country of ref document:EP Kind code of ref document:A2 | |
| NENP | Non-entry into the national phase | Ref country code:DE | |
| WWE | Wipo information: entry into national phase | Ref document number:2011724475 Country of ref document:EP |